Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Intraday Update
  • Markets
  • News

What Does Biora Therapeutics’ Debt Look Like?

By Benzinga Insights
Today, 7:19 AM
Over the past three months, shares of Biora Therapeutics Inc. (NASDAQ:BIOR) moved lower by 46.87%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.

BIOR

Read More
2 minute read
  • Intraday Update
  • Markets
  • News

Biora Therapeutics’ Debt Overview

By Benzinga Insights
Today, 7:19 AM
Over the past three months, shares of Biora Therapeutics Inc. (NASDAQ:BIOR) decreased by 61.54%. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its financials.

BIOR

Read More
1 minute read
  • News

Biora Therapeutics Says On Jan. 19, 2023 Co. Received Notice Of Delisting Or Failure To Satisfy Continued Listing Rule Or Standard From Nasdaq

By Michael Horton
Today, 7:19 AM
-SEC Filing

BIOR

Read More
2 minute read
  • Biotech
  • FDA
  • General
  • News

Biora Therapeutics Presents Data From Device Performance Study With Repeat Doses In Both Fasted And Fed States At Crohn’s & Colitis Congress

By Benzinga Newsdesk
Today, 7:19 AM
 Biora Therapeutics, Inc.

BIOR

Read More
2 minute read
  • Movers

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights
Today, 7:19 AM
Gainers SmileDirectClub (NASDAQ:SDC) stock increased by 47.0% to $0.71 during Monday’s regular session. SmileDirectClub’s stock is trading at…

ATIP

Read More
3 minute read
  • Exclusives
  • Penny Stocks
  • Small Cap
  • Top Stories
  • Trading Ideas

Benzinga ‘Stock Whisper’ Index: 5 Stocks Investors Are Secretly Monitoring, But Not Yet Talking About

By Chris Katje
Today, 7:19 AM
Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. Retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming.

AMV

Read More
2 minute read
  • Markets
  • Movers
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Small Cap
  • Trading Ideas

Why Akerna Shares Are Trading Higher By 97%; Here Are 20 Stocks Moving Premarket

By Lisa Levin
Today, 7:19 AM
Gainers Akerna Corp. (NASDAQ: KERN) rose 97.4% to $1.91 in pre-market trading after the company reported the sale of 365 Cannabis for $2.8 million.

ACER

Read More
1 minute read
  • Biotech
  • General
  • News

Biora Therapeutics Has Been Granted U.S. Patent Number 11,547,301 Titled “Methods For Collecting And Testing Bacteria Containing Samples From Within The Gastrointestinal Tract” – USPTO

By Benzinga Newsdesk
Today, 7:19 AM
https://ppubs.uspto.gov/pubwebapp/external.html?q=(11547301).pn

BIOR

Read More
2 minute read
  • FDA
  • Movers
  • News
  • Stock Split

What’s Going On With Biora Therapeutics Stock?

By Adam Eckert
Today, 7:19 AM
Biora Therapeutics Inc (NASDAQ: BIOR) shares are trading higher on abnormally-high volume Wednesday. Here's a look at what's going on.

BIOR

Read More
2 minute read
  • Cryptocurrency
  • Markets
  • News
  • Small Cap

Tesla, Amazon, Biora Therapeutics, Riot Platforms, Netflix: Why These 5 Stocks Are Drawing Investors’ Attention Today

By Bhavik Nair
Today, 7:19 AM
Major Wall Street indices closed in the green on Tuesday as investors and traders kept their eyes glued to the crucial consumer price inflation data due on Thursday. Federal Reserve Chair Jerome Powell

AMZN

Posts navigation

1 2 … 4 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service